Janney Montgomery Scott LLC Acquires 654 Shares of CME Group Inc. $CME

Janney Montgomery Scott LLC lifted its position in shares of CME Group Inc. (NASDAQ:CME) by 1.2% during the second quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 57,464 shares of the financial services provider’s stock after buying an additional 654 shares during the quarter. Janney Montgomery Scott LLC’s holdings in CME Group were worth $15,838,000 at the end of the most recent quarter.

A number of other hedge funds and other institutional investors have also made changes to their positions in CME. Great Lakes Advisors LLC boosted its position in CME Group by 2.3% during the first quarter. Great Lakes Advisors LLC now owns 1,661 shares of the financial services provider’s stock valued at $441,000 after purchasing an additional 37 shares in the last quarter. Beaumont Financial Advisors LLC boosted its position in CME Group by 2.0% during the second quarter. Beaumont Financial Advisors LLC now owns 1,952 shares of the financial services provider’s stock valued at $538,000 after purchasing an additional 38 shares in the last quarter. SeaCrest Wealth Management LLC boosted its position in CME Group by 3.0% during the first quarter. SeaCrest Wealth Management LLC now owns 1,379 shares of the financial services provider’s stock valued at $366,000 after purchasing an additional 40 shares in the last quarter. OneAscent Financial Services LLC boosted its position in CME Group by 4.0% during the first quarter. OneAscent Financial Services LLC now owns 1,106 shares of the financial services provider’s stock valued at $293,000 after purchasing an additional 43 shares in the last quarter. Finally, Highline Wealth Partners LLC boosted its position in CME Group by 84.3% during the second quarter. Highline Wealth Partners LLC now owns 94 shares of the financial services provider’s stock valued at $26,000 after purchasing an additional 43 shares in the last quarter. Institutional investors own 87.75% of the company’s stock.

Wall Street Analysts Forecast Growth

A number of equities research analysts recently weighed in on the company. Oppenheimer raised their price objective on CME Group from $300.00 to $303.00 and gave the company an “outperform” rating in a research report on Thursday, July 24th. Piper Sandler raised their price objective on CME Group from $283.00 to $296.00 and gave the company an “overweight” rating in a research report on Tuesday, July 15th. Wall Street Zen downgraded CME Group from a “hold” rating to a “sell” rating in a research report on Sunday, July 13th. Citigroup upgraded CME Group from a “neutral” rating to a “buy” rating and increased their price target for the company from $275.00 to $300.00 in a research note on Thursday, September 25th. Finally, Barclays set a $298.00 price objective on CME Group and gave the stock an “equal weight” rating in a research note on Thursday, July 24th. Five equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, CME Group has an average rating of “Hold” and a consensus price target of $274.15.

Insider Buying and Selling

In other news, General Counsel Jonathan L. Marcus sold 392 shares of the business’s stock in a transaction that occurred on Thursday, September 18th. The stock was sold at an average price of $262.00, for a total value of $102,704.00. Following the completion of the sale, the general counsel directly owned 7,851 shares in the company, valued at $2,056,962. The trade was a 4.76% decrease in their ownership of the stock. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider Timothy Francis Mccourt sold 379 shares of the business’s stock in a transaction that occurred on Tuesday, September 16th. The shares were sold at an average price of $259.83, for a total value of $98,475.57. Following the completion of the sale, the insider owned 9,508 shares of the company’s stock, valued at $2,470,463.64. This trade represents a 3.83% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 13,043 shares of company stock valued at $3,527,956 in the last ninety days. Insiders own 0.30% of the company’s stock.

CME Group Trading Down 0.2%

Shares of NASDAQ:CME opened at $265.43 on Friday. The business has a 50-day moving average price of $270.28 and a 200-day moving average price of $271.11. The company has a quick ratio of 1.02, a current ratio of 1.02 and a debt-to-equity ratio of 0.12. The stock has a market cap of $95.66 billion, a price-to-earnings ratio of 25.70, a PEG ratio of 4.83 and a beta of 0.41. CME Group Inc. has a 52-week low of $213.94 and a 52-week high of $290.79.

CME Group (NASDAQ:CME) last announced its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share for the quarter, beating the consensus estimate of $2.91 by $0.05. The company had revenue of $1.69 billion during the quarter, compared to analysts’ expectations of $1.68 billion. CME Group had a return on equity of 14.60% and a net margin of 58.48%.CME Group’s quarterly revenue was up 10.4% on a year-over-year basis. During the same period last year, the business earned $2.56 earnings per share. Equities analysts predict that CME Group Inc. will post 10.49 EPS for the current year.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Investors of record on Tuesday, September 9th were given a dividend of $1.25 per share. This represents a $5.00 annualized dividend and a yield of 1.9%. The ex-dividend date was Tuesday, September 9th. CME Group’s dividend payout ratio (DPR) is currently 48.40%.

CME Group Company Profile

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.